Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$TBLT volume 6M triple the float
Short interest increased to 197.98 % from 180.38%
and still On Threshold List
$TBLT Short interest increased to 196 % from 180.38%
and still On Threshold List
$TBLT Short interest increased to 196 % from 180.38%
and still On Threshold List
$TBLT Strong short squeeze candidate
TBLT Short interest 180.38 % ~ 287.23%
also On Threshold List
Float 2.13M ~ 977.8 K
Sources ORTEX ~ Etrade
Cost to Borrow Average 369 %
Utilization % 100%
Tangible Book Value $47,737M (Yahoo Finance)
Revenue (ttm) $74.96M
Book Value Per Share (mrq) $55.38
% Held by Insiders 27.97%
% Held by Institutions 8.77%
Daily Chart
$TBLT Strong short squeeze candidate
TBLT Short interest 180.38 % ~ 287.23%
also On Threshold List
Float 2.13M ~ 977.8 K
Sources ORTEX ~ Etrade
Cost to Borrow Average 369 %
Utilization % 100%
Tangible Book Value $47,737M (Yahoo Finance)
Revenue (ttm) $74.96M
Book Value Per Share (mrq) $55.38
% Held by Insiders 27.97%
% Held by Institutions 8.77%
Daily Chart
$TBLT Strong short squeeze candidate
Tangible Book Value$47,737M
Revenue (ttm) $74.96M
Book Value Per Share (mrq) $55.38
% Held by Insiders 27.97%
% Held by Institutions 8.77%
Strong short squeeze candidate
Tangible Book Value$47,737M
Revenue (ttm) $74.96M
Book Value Per Share (mrq) $55.38
% Held by Insiders 27.97%
% Held by Institutions 8.77%
Strong short squeeze candidate
Tangible Book Value$47,737M
Revenue (ttm) $74.96M
Book Value Per Share (mrq) $55.38
% Held by Insiders 27.97%
% Held by Institutions 8.77%
$AEI Form 4
Mr. Chan owns 79,464,271
https://www.otcmarkets.com/filing/conv_pdf?id=15955368&guid=lvU-ka3VoTP2B3h
$AEI Form 4
Mr. Chan owns 79,464,271
https://www.otcmarkets.com/filing/conv_pdf?id=15955368&guid=lvU-ka3VoTP2B3h
$TBLT Short interest 156.21 % ~ 287.23%
Float 2.13M ~ 977.8 K
Sources ORTEX ~ Etrade
Cost to Borrow Avg 396.16 %
Utilization % 100%
$TBLT Short interest 156.21 % ~ 287.23%
Float 2.13M ~ 977.8 K
Sources ORTEX ~ Etrade
Cost to Borrow Avg 396.16 %
Utilization % 100%
$AEI Important read $PRPH CEO talks about Equivir from Impact Biomedical /DSS.
https://stocktwits.com/johannn/message/472094648
0:27:34 equivir Q/A next year in the stores.
0:45;04 Collaboration with impact / Global Research and Discovery Group (GRDG) .Billions
https://renmark-drupal.s3.amazonaws.com/vndr/ProPhase-Labs-Inc/2022-07-13/index.html
$AEI Important read $PRPH CEO talks about Equivir from Impact Biomedical /DSS.
https://stocktwits.com/johannn/message/472094648
0:27:34 equivir Q/A next year in the stores.
0:45;04 Collaboration with impact / Global Research and Discovery Group (GRDG) .Billions
https://renmark-drupal.s3.amazonaws.com/vndr/ProPhase-Labs-Inc/2022-07-13/index.html
$AEI 173k covered to be exact.
$AEI they cover the shorts for only one reason. They think the stock is going higher.
$AEI this is today
Returned Shares 100.8k
Borrowed Shares 167.6k
$AEI you need to read this by Powerbattles
AMERICAN MEDICAL REIT, INC.
The Holder listed below hereby irrevocably exercises his/her/its right to convert ($__________) of this Note into __________________ shares of Common Stock of American Medical REIT, Inc. at the Conversion Price of $10.00 per share in accordance with the terms of this Note, and directs that the Common Stock issuable and deliverable upon such conversion be recorded on the books of American Medical REIT, Inc. in the name of, and delivered to, the
https://www.sec.gov/Archives/edgar/data/1750106/000149315222005518/ex10-2.htm
$AEI you need to read this by Powerbattles
AMERICAN MEDICAL REIT, INC.
The Holder listed below hereby irrevocably exercises his/her/its right to convert ($__________) of this Note into __________________ shares of Common Stock of American Medical REIT, Inc. at the Conversion Price of $10.00 per share in accordance with the terms of this Note, and directs that the Common Stock issuable and deliverable upon such conversion be recorded on the books of American Medical REIT, Inc. in the name of, and delivered to, the
https://www.sec.gov/Archives/edgar/data/1750106/000149315222005518/ex10-2.htm
$APRN Short squeeze and Gamma squeeze candidate
Citron Research $40 Price Target
https://citronresearch.com/wp-content/uploads/2022/01/Blue-Apron-The-Answer-to-Food-Inflation.pdf
PRICE TARGET AND CONSENSUS RATING
$APRN Joe Sanberg owns 43.2% of the company’s OS
https://worldnewsera.com/news/finance/stock-market/aprn-long-term-value-with-squeeze-potential-for-nyseaprn-by-penny_stocks_today/
Float 17M
Short Interest 28.16 %
Utilization 100% (no shares to short)
% Freefloat on Loan 38.72%
Cost to Borrow average 44.81%
Cost to Borrow max 49.41 %
49.15% % of Shares Held by Insiders (Yahoo Finance)
32.91% % of Shares Held by Institutions
64.72% % of Float Held by Institutions
Blue Apron starts offering meal kits through http://Walmart.com
https://finance.yahoo.com/m/feec48fa-b3d6-3ca9-9496-cf6665cac1fe/blue-apron-starts-offering.html
$APRN Short squeeze and Gamma squeeze candidate
Citron Research $40 Price Target
https://citronresearch.com/wp-content/uploads/2022/01/Blue-Apron-The-Answer-to-Food-Inflation.pdf
PRICE TARGET AND CONSENSUS RATING
$APRN Joe Sanberg owns 43.2% of the company’s OS
https://worldnewsera.com/news/finance/stock-market/aprn-long-term-value-with-squeeze-potential-for-nyseaprn-by-penny_stocks_today/
Float 17M
Short Interest 28.16 %
Utilization 100% (no shares to short)
% Freefloat on Loan 38.72%
Cost to Borrow average 44.81%
Cost to Borrow max 49.41 %
49.15% % of Shares Held by Insiders (Yahoo Finance)
32.91% % of Shares Held by Institutions
64.72% % of Float Held by Institutions
Blue Apron starts offering meal kits through http://Walmart.com
https://finance.yahoo.com/m/feec48fa-b3d6-3ca9-9496-cf6665cac1fe/blue-apron-starts-offering.html
$AEI now the largest stockholder of DSS, we control DSS IPO spinoffs and share distribution!
$AEI "The Company (including its majority-owned subsidiaries) is the largest stockholder of DSS."
New filing 8K
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001750106/000149315222019330/form8-k.htm
$AEI "The Company (including its majority-owned subsidiaries) is the largest stockholder of DSS."
New filing 8K
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001750106/000149315222019330/form8-k.htm
$AEI owns 35.22% of DSS
"AEI beneficially owns 41,446,087 shares of the Company’s common stock which equals 35.22% of the Company’s outstanding shares and Heng Fai Ambrose Chan beneficially owns 51.02% of the Company’s outstanding shares based on 117,650,995 shares of the common stock of the Company outstanding as of July 7, 2022"
https://www.otcmarkets.com/filing/conv_pdf?id=15940603&guid=OzU-kaxCCodpiih
$RGBP $.0046 and $RGBPP $.023 mRNA Vaccine Patent #3
- 8 Granted Patents
- 13 Published Applications
- 2 Investigational New Drug applications (IND) filed with the FDA
- 3 Products in preclinical development based on the newly discovered cancer stem cell gene target
(b) Regen has granted an exclusive license to Oncology Pharma, Inc. to develop and commercialize "Antigen specific mRNA cellular cancer vaccines" for the treatment of pancreatic cancer.
https://www.prnewswire.com/news-releases/regen-biopharma-inc-responds-to-numerous-requests-for-updates-on-its-intellectual-property-ip-portfolio-301504448.html
Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine
Oncology Pharma ( $ONPH ) $1.57
52 Week high $28.8
https://finance.yahoo.com/news/oncology-pharma-inc-regen-biopharma-123000344.html
$RGBP $.0046 and $RGBPP $.023 mRNA Vaccine Patent #3
- 8 Granted Patents
- 13 Published Applications
- 2 Investigational New Drug applications (IND) filed with the FDA
- 3 Products in preclinical development based on the newly discovered cancer stem cell gene target
(b) Regen has granted an exclusive license to Oncology Pharma, Inc. to develop and commercialize "Antigen specific mRNA cellular cancer vaccines" for the treatment of pancreatic cancer.
https://www.prnewswire.com/news-releases/regen-biopharma-inc-responds-to-numerous-requests-for-updates-on-its-intellectual-property-ip-portfolio-301504448.html
Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine
Oncology Pharma ( $ONPH ) $1.57
52 Week high $28.8
https://finance.yahoo.com/news/oncology-pharma-inc-regen-biopharma-123000344.html
$AEI Company website https://www.alsetinc.com/
click on Happi Wealth, then click on PRE-IPO INVESTMENT
$APRN Citron Research $40 Price Target
https://citronresearch.com/wp-content/uploads/2022/01/Blue-Apron-The-Answer-to-Food-Inflation.pdf
$APRN Joe Sanberg owns 43.2% of the company’s OS
https://worldnewsera.com/news/finance/stock-market/aprn-long-term-value-with-squeeze-potential-for-nyseaprn-by-penny_stocks_today/
Float 17M
Short Interest 32.34% (ORTEX live data)
Utilization 100% (no shares to short)
% Freefloat on Loan 45.71%
Cost to Borrow average 62.3 %
Cost to Borrow max 92.82 %
49.15% % of Shares Held by Insiders (Yahoo Finance)
32.91% % of Shares Held by Institutions
64.72% % of Float Held by Institutions
Blue Apron starts offering meal kits through http://Walmart.com
https://finance.yahoo.com/m/feec48fa-b3d6-3ca9-9496-cf6665cac1fe/blue-apron-starts-offering.html
Daily Chart
$APRN Citron Research $40 Price Target
https://citronresearch.com/wp-content/uploads/2022/01/Blue-Apron-The-Answer-to-Food-Inflation.pdf
$APRN Joe Sanberg owns 43.2% of the company’s OS
https://worldnewsera.com/news/finance/stock-market/aprn-long-term-value-with-squeeze-potential-for-nyseaprn-by-penny_stocks_today/
Float 17M
Short Interest 32.34% (ORTEX live data)
Utilization 100% (no shares to short)
% Freefloat on Loan 45.71%
Cost to Borrow average 62.3 %
Cost to Borrow max 92.82 %
49.15% % of Shares Held by Insiders (Yahoo Finance)
32.91% % of Shares Held by Institutions
64.72% % of Float Held by Institutions
Blue Apron starts offering meal kits through http://Walmart.com
https://finance.yahoo.com/m/feec48fa-b3d6-3ca9-9496-cf6665cac1fe/blue-apron-starts-offering.html
Daily Chart
$APRN Float is only 17M
Take into account
% Freefloat on Loan 45.71% (live data)
64.72% % of Float Held by Institutions
tiny float
Short Interest 32.84% (live data)
Utilization 100% (no shares to short)
49.15% % of Shares Held by Insiders
32.91% % of Shares Held by Institutions
$APRN Float is only 17M
Take into account
% Freefloat on Loan 45.71% (live data)
64.72% % of Float Held by Institutions
tiny float
Short Interest 32.84% (live data)
Utilization 100% (no shares to short)
49.15% % of Shares Held by Insiders
32.91% % of Shares Held by Institutions
$APRN Citron Research $40 Price Target
https://citronresearch.com/wp-content/uploads/2022/01/Blue-Apron-The-Answer-to-Food-Inflation.pdf
Short Interest 32.37%
Utilization 100%
Top Reddit ShortSqueeze Mentions for July 4th Weekend: APRN, BBIG, EVFM, ENDP, SFT, RDBX, GME, ATER, REV, AMC.
I found this Video on $AEI website boxabl and Elon Musk mentioned ???!!!
The INSANE New $13,000 Tesla Mini-House For Affordable Living!
http://alsetinc.com/videos scroll down
AEI owns 28.2% equity interest in DSS is a multinational company operating businesses within nine divisions: product packaging, biotechnology, direct marketing, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy. DSS Inc. is listed on the NYSE (NYSE: DSS).
DSS, INC. Structure
$AEI DSS, Inc. Exclusive Investor Zoom
Shareholders value through subsidiary IPO or Spinoff